Aarhus, Denmark

Thomas Vorup Jensen

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Vorup Jensen. Retrieved from https://idiyas.com/inventor/thomas-vorup-jensen-jnn8jxxs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Thomas Vorup Jensen

Introduction

Thomas Vorup Jensen is a notable inventor based in Arhus, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions.

Latest Patents

His most recent patent is titled "Recombinant human mannan-binding lectin." This invention relates to methods of producing and isolating MBL compositions. Specifically, it focuses on creating novel recombinant human MBL preparations that closely resemble natural human MBL. These preparations have potential applications in medicaments and treatment methods for conditions associated with immunosuppressive states and MBL deficiencies. Such deficiencies are linked to an increased susceptibility to infections.

Career Highlights

Throughout his career, Thomas Vorup Jensen has demonstrated a commitment to advancing medical science through his innovative work. His research has the potential to impact the treatment of various health conditions, making him a valuable contributor to the field.

Collaborations

He has collaborated with notable colleagues, including Steffen Thiel and Jens Christian Jensenius, to further his research and development efforts.

Conclusion

Thomas Vorup Jensen's work in recombinant human mannan-binding lectin showcases his dedication to innovation in biotechnology. His contributions are poised to enhance therapeutic options for individuals with MBL deficiencies and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…